According to FutureWise analysis the market for desmoid tumor in 2023 is US$ 3.06 billion, and is expected to reach US$ 4.63 billion by 2031 at a CAGR of 5.32%.
The desmoid tumor can be a rare condition. Desmoid tumors develop from cells called fibroblasts. These cells can be found all over the body and provide structural support, protection, and a crucial role in wound healing. Although most often found in women in their thirties and thirties these tumors can occur at any age. They can grow slowly or become malignant. But, fibromatosis aggressively can cause serious complications and even death. It is a localized form of disease that compresses vital organs like the intestines. Although most cases are not serious, there are some cases that are linked to familial FAB polyposis. Desmoid tumors are found in approximately 10% of Gardner's Syndrome patients. There are three types of desmoid tumors: extra-abdomen, stomach wall, and intra-abdominal. The latter is more common for patients with FAP. The lesions can be related to estrogen or trauma/ procedures. A 3' APC mutation in FAP patients is the leading risk factor for intra-abdominal desmoid formation. FAP patients who have an abdominal wall desmoid prior to surgery are at an increased chance of developing an intra-abdominal desmoid. Breast desmoid tumors are uncommon. Although benign, desmoid tumors of the breast can mimic breast carcinoma on physical examination, mammography, and breast ultrasound. They can also be localized invasive. Although they may only occur occasionally, they can also be diagnosed as part of Gardner’s syndrome. Rare lesions, such as desmoid tumors of the breast, require a high level of suspicion and a triple exam protocol. A desmoid tumor of the breast can be difficult to diagnose, especially when imaging studies are not conclusive. This could lead to a more grave diagnosis. Waiting, surgical Removal, radiation treatment, and antiestrogens may be used. Tamoxifen NSAIDs or treatment (cold/heat, ultrasound). A multi-disciplinary team including surgeons, radiologists, medical oncologists, geneticists, and radiation oncologists should evaluate patients with desmoid tumors. There is no cure for desmoid tumors. Patients should consider enrolling in clinical trials if possible.
A biopsy is the only way to definitively determine the type of tumor. The main problem with these lesions is the high incidence of recurrences in FAP-associated diseases. For intra-abdominal fibrosis, even if there is no evidence of FAP, it appears that the risk of recurrence for this condition is lower. To reduce the risk of recurrence, wide surgical resection is the most commonly used technique. This can be done with either radiation, chemotherapy, or hormonal therapy.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Desmoid Tumor Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Desmoid Tumor Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.